Effect of age at menarche on microvascular complications among women with Type 1 diabetes

To test the hypothesis that delayed menarche is associated with an increased microvascular complication risk among women with Type 1 diabetes.

[1]  C. Forsblom,et al.  Age at menarche and the risk of diabetic microvascular complications in patients with type 1 diabetes , 2016, Diabetologia.

[2]  A. Juul,et al.  Recent Secular Trends in Pubertal Timing: Implications for Evaluation and Diagnosis of Precocious Puberty , 2012, Hormone Research in Paediatrics.

[3]  E. Codner,et al.  Contraception, and pregnancy in adolescents with type 1 diabetes: a review , 2012, Pediatric diabetes.

[4]  J. Snell-Bergeon,et al.  Menarche delay and menstrual irregularities persist in adolescents with type 1 diabetes , 2011, Reproductive biology and endocrinology : RB&E.

[5]  J. Snell-Bergeon,et al.  Menarchal Timing in Type 1 Diabetes Through the Last 4 Decades , 2010, Diabetes Care.

[6]  A. Deltsidou.  Age at menarche and menstrual irregularities of adolescents with type 1 diabetes. , 2010, Journal of pediatric and adolescent gynecology.

[7]  C. Schmid,et al.  A new equation to estimate glomerular filtration rate. , 2009, Annals of internal medicine.

[8]  G. Salzano,et al.  Menarcheal timing in intensively treated girls with type 1 diabetes mellitus. , 2009, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[9]  P. Pozzilli,et al.  Menarche in type 1 diabetes is still delayed despite good metabolic control. , 2008, Fertility and sterility.

[10]  I. Knerr,et al.  Delayed menarche in young German women with type 1 diabetes mellitus: recent results from the DPV diabetes documentation and quality management system , 2008, European Journal of Pediatrics.

[11]  S. Hadjadj,et al.  Effect of raloxifene—a selective oestrogen receptor modulator—on kidney function in post‐menopausal women with Type 2 diabetes: results from a randomized, placebo‐controlled pilot trial , 2007, Diabetic medicine : a journal of the British Diabetic Association.

[12]  M. McDowell,et al.  Has age at menarche changed? Results from the National Health and Nutrition Examination Survey (NHANES) 1999-2004. , 2007, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

[13]  T. Remer,et al.  Exaggerated adrenarche and altered cortisol metabolism in Type 1 diabetic children , 2006, Steroids.

[14]  M. Palta,et al.  The association of increased total glycosylated hemoglobin levels with delayed age at menarche in young women with type 1 diabetes. , 2005, The Journal of clinical endocrinology and metabolism.

[15]  D. Mook-Kanamori,et al.  Ovarian function during puberty in girls with type 1 diabetes mellitus: response to leuprolide. , 2005, The Journal of clinical endocrinology and metabolism.

[16]  Yongmei Liu,et al.  The relationship between albuminuria and hormone therapy in postmenopausal women. , 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[17]  R. Burcelin,et al.  Printed in U.S.A. Copyright © 2003 by The Endocrine Society doi: 10.1210/en.2003-0457 Gonadotropin-Releasing Hormone Secretion from Hypothalamic Neurons: Stimulation by Insulin and , 2022 .

[18]  W. Sutherland,et al.  HRT does not improve urinary albumin excretion in postmenopausal diabetic women. , 2003, Diabetes research and clinical practice.

[19]  S. Berga,et al.  Menstrual cycle differences between women with type 1 diabetes and women without diabetes. , 2003, Diabetes care.

[20]  L. de Jong-van den Berg,et al.  Oral contraceptive use and hormone replacement therapy are associated with microalbuminuria. , 2001, Archives of Internal Medicine.

[21]  R. Klein,et al.  Role of brain insulin receptor in control of body weight and reproduction. , 2006, Science.

[22]  Rüdiger Klein,et al.  Role of Brain Insulin Receptor in Control of Body Weight and Reproduction , 2000 .

[23]  Z. Vajo,et al.  Postmenopausal hormone replacement improves proteinuria and impaired creatinine clearance in type 2 diabetes mellitus and hypertension , 2000, BJOG : an international journal of obstetrics and gynaecology.

[24]  M. Šnajderová,et al.  Premenarchal and postmenarchal girls with insulin-dependent diabetes mellitus: ovarian and other organ-specific autoantibodies, menstrual cycle. , 1999, Journal of Pediatric and Adolescent Gynecology.

[25]  T. J. Berg,et al.  Increased Serum Levels of Advanced Glycation End Products (AGEs) in Children and Adolescents With IDDM , 1997, Diabetes Care.

[26]  A. Tenore,et al.  Pubertal Growth, Sexual Maturation, and Final Height in Children With IDDM: Effects of age at onset and metabolic control , 1997, Diabetes Care.

[27]  M. Karp,et al.  Menstrual characteristics of women suffering from insulin-dependent diabetes mellitus. , 1995, International journal of fertility and menopausal studies.

[28]  M B Brown,et al.  A Practical Two-Step Quantitative Clinical and Electrophysiological Assessment for the Diagnosis and Staging of Diabetic Neuropathy , 1994, Diabetes Care.

[29]  L. Kuller,et al.  Prevalence of Complications in IDDM by Sex and Duration: Pittsburgh Epidemiology of Diabetes Complications Study II , 1990, Diabetes.

[30]  L. Kuller,et al.  Factors Associated With Avoidance of Severe Complications After 25 Yr of IDDM: Pittsburgh Epidemiology of Diabetes Complications Study I , 1990, Diabetes Care.

[31]  D. Daneman,et al.  The relationship of metabolic control to growth and pubertal development in children with insulin-dependent diabetes. , 1985, Diabetes research.